We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$150M
AUM Growth
-$19.5M
Cap. Flow
-$10.6M
Cap. Flow %
-7.05%
Top 10 Hldgs %
52.92%
Holding
99
New
9
Increased
16
Reduced
55
Closed
13

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.62M
2
LLY icon
Eli Lilly
LLY
+$1.28M
3
HCAT icon
Health Catalyst
HCAT
+$1.27M
4
PRVA icon
Privia Health
PRVA
+$1.03M
5
CLOV icon
Clover Health Investments
CLOV
+$983K

Top Sells

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$1.8M
2
ZBH icon
Zimmer Biomet
ZBH
+$1.46M
3
ICLR icon
Icon
ICLR
+$1.32M
4
EW icon
Edwards Lifesciences
EW
+$1.26M
5
OPCH icon
Option Care Health
OPCH
+$1.25M

Sector Composition

Rank Sector Weight
1 Healthcare 99.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
26
Intuitive Surgical
ISRG
$126B
$1.59M 1.06%
3,050
– –
PCVX icon
27
Vaxcyte
PCVX
$7.81B
$1.55M 1.04%
18,950
+4,410
+30% +$438K
VRTX icon
28
Vertex Pharmaceuticals
VRTX
$120B
$1.48M 0.99%
3,670
-1,170
-24% -$542K
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.59B
$1.34M 0.89%
11,020
-1,296
-11% -$159K
GPCR icon
30
Structure Therapeutics
GPCR
$3.35B
$1.34M 0.89%
49,250
+24,855
+102% +$882K
MLTX icon
31
MoonLake Immunotherapeutics
MLTX
$1.57B
$1.28M 0.86%
23,687
-3,571
-13% -$182K
FOLD
32
DELISTED
Amicus Therapeutics
FOLD
$1.28M 0.85%
135,620
-5,715
-4% -$59.4K
QURE icon
33
uniQure
QURE
$3.02B
$1.26M 0.84%
71,500
-81,500
-53% -$704K
ZLAB icon
34
Zai Lab
ZLAB
$2.05B
$1.17M 0.78%
44,800
-28,070
-39% -$779K
CYTK icon
35
Cytokinetics
CYTK
$10.6B
$1.15M 0.77%
24,500
-4,093
-14% -$213K
HCAT icon
36
Health Catalyst
HCAT
$152M
$1.13M 0.76%
+160,000
New +$1.27M
TARS icon
37
Tarsus Pharmaceuticals
TARS
$2.53B
$1.12M 0.75%
20,300
+9,000
+80% +$409K
SPRY icon
38
ARS Pharmaceuticals
SPRY
$523M
$1.12M 0.75%
106,007
+7,367
+7% +$103K
BPMC
39
DELISTED
Blueprint Medicines
BPMC
$1.1M 0.73%
12,560
-2,360
-16% -$216K
RCUS icon
40
Arcus Biosciences
RCUS
$3.48B
$1.04M 0.69%
69,552
-5,970
-8% -$97.5K
PRVA icon
41
Privia Health
PRVA
$2.97B
$1.02M 0.68%
+52,000
New +$1.03M
CVS icon
42
CVS Health
CVS
$134B
$988K 0.66%
22,000
-3,500
-14% -$196K
LEGN icon
43
Legend Biotech
LEGN
$3.57B
$970K 0.65%
29,800
+2,600
+10% +$108K
AZN icon
44
AstraZeneca
AZN
$264B
$960K 0.64%
7,325
-3,345
-31% -$468K
CLOV icon
45
Clover Health Investments
CLOV
$2.25B
$866K 0.58%
+275,000
New +$983K
SGOV icon
46
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.4B
$803K 0.54%
8,000
-7,200
-47% -$723K
NARI
47
DELISTED
Inari Medical, Inc. Common Stock
NARI
$774K 0.52%
15,153
-9,847
-39% -$484K
CI icon
48
Cigna
CI
$74.9B
$621K 0.41%
+2,250
New +$717K
IOVA icon
49
Iovance Biotherapeutics
IOVA
$1.88B
$603K 0.4%
+81,500
New +$755K
BIIB icon
50
Biogen
BIIB
$30.1B
$589K 0.39%
3,852
-2,175
-36% -$367K
1
2
3 4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sectoral Asset Management held 99 positions worth $150M, down 12% from $169M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sectoral Asset Management withdrew a net $10.6M in Q4 2024, closing 13 positions and reducing 55 holdings. Its most notable exit was IQVIA, an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in Health Catalyst worth $1.13M.

  • Sectoral Asset Management's largest Q4 2024 buy was Health Catalyst: 160,000 shares worth $1.13M.
  • Sectoral Asset Management added most to Amgen in Q4 2024, an estimated $1.62M increase.
  • Sectoral Asset Management's biggest Q4 2024 reduction was Edwards Lifesciences, cutting an estimated $1.26M.
  • Sectoral Asset Management fully exited IQVIA in Q4 2024, selling an estimated $1.8M.
  • Sectoral Asset Management's ten largest holdings make up 53% of its $150M portfolio in Q4 2024.
  • Sectoral Asset Management opened 9 new positions and closed 13 in Q4 2024.
  • Sectoral Asset Management's portfolio value fell 12% quarter-over-quarter to $150M.

Based on Sectoral Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.